Moderna publishes interim results from older adults in phase 1 study of its COVID-19 vaccine Read more
Bispecific antibodies will mature after 2021, $6bn estimated sales in oncology by 2025: GlobalData Read more
Developing herd immunity without pharma interventions may have detrimental consequences: Choubey Read more
Sorrento gets US FDA nod for Phase 1 clinical trial of neutralising antibody in COVID-19 patients Read more